Immunome, Inc.IMNMNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+80.8%
5Y CAGR+80.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+80.8%/yr
vs +47.8%/yr prior
5Y CAGR
+80.1%/yr
Consistent
Acceleration
+33.1pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
19x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $218.10M | -30.7% |
| 2024 | $314.84M | +154.8% |
| 2023 | $123.55M | +234.8% |
| 2022 | $36.90M | +46.4% |
| 2021 | $25.20M | +119.1% |
| 2020 | $11.51M | +11.2% |
| 2019 | $10.35M | +33.6% |
| 2018 | $7.74M | - |